Serological markers for prediction of response to anti-tumor necrosis factor treatment in Crohn's disease

Abstract

In this cohort of infliximab-treated patients, neither ASCA nor pANCA could predict response to treatment. However, the combination pANCA+/ASCA- might warrant further investigation for its value in predicting nonresponse in patients with refractory luminal disease.

References

Page 1

	Year	Citations
Development of a Crohn's disease activity index. National Cooperative Crohn's Disease Study. William R. Best, Jack M. Becktel, John W. Singleton, PubMed	1976	3.2K
A Short-Term Study of Chimeric Monoclonal Antibody cA2 to Tumor Necrosis Factor α for Crohn's Disease Stephan R. Targan, Stephen B. Hanauer, Sander J. H. van Deventer, New England Journal of Medicine	1997	3.1K
Development of a Crohn's Disease Activity Index William R. Best, Jack M. Becktel, John W. Singleton, Gastroenterology Functional Gastrointestinal DisorderDisease Activity IndexGastroenterologyUlcerative ColitisEpidemiology	1976	3.1K
Infliximab for the Treatment of Fistulas in Patients with Crohn's Disease Daniel H. Present, Paul Rutgeerts, Stephan Targan, New England Journal of Medicine	1999	2.7K
Classification of Inflammatory Bowel Disease J E Lennard‐Jones Scandinavian Journal of Gastroenterology InflammationRheumatologyFunctional Gastrointestinal DisorderAutoimmune DiseaseAbdominal Imaging	1989	2K
Endoscopic and histological healing with infliximab anti–tumor necrosis factor antibodies in Crohn's disease: A European multicenter trial Geert D’Haens, Sander van Deventer, Ruud van Hogezand, Gastroenterology InflammationAnti-inflammatoryAutoimmune DiseaseImmunologyGastroenterology	1999	753
Anti- <i>Saccharomyces cerevisiae</i> mannan antibodies combined with antineutrophil cytoplasmic autoantibodies in inflammatory bowel disease: prevalence and diagnostic role J F Quinton, Boualem Sendid, Dominique Reumaux, Gut	1998	571
Tumor necrosis factor α antibody (infliximab) therapy profoundly down-regulates the inflammation in Crohn's ileocolitis Filip J. Baert, Geert D’Haens, Marc Peeters, Gastroenterology InflammationChronic Inflammatory DiseasesTumor Necrosis FactorAnti-inflammatoryMucosal Immunology	1999	467
Diagnostic accuracy of serological assays in pediatric inflammatory bowel disease Frank M. Ruemmele, Stephan R. Targan, Galith Levy, Gastroenterology Functional Gastrointestinal DisorderMedicineDiagnostic TestDiagnosisPathology	1998	385
Antibody to Saccharomyces cerevisiae (bakers' yeast) in Crohn's disease. Janice Main, Harold C. McKenzie, Grant R. Yeaman, BMJ D'anticorps IggAutoimmune DiseaseMicrobial PathogensSaccharomyces CerevisiaeMucosal Immunology	1988	331

Page 1